MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    A low-cost system using a big-data deep-learning framework for assessing physical tele-rehabilitation: a proof-of-concept

    A. Olivares-Gil, JM. Ramírez-Sanz, JL. Garrido-Labrador, á. García-Bustillo, á. Arnaiz-González, JF. Díez-Pastor, J. González-Santos, JJ. González-Bernal, M. Allende-Río, F. Valiñas-Sieiro, JM. Trejo-Gabriel-Galan, E. Cubo (Burgos, Spain)

    Objective: The consolidation of tele-rehabilitation for the treatment of many diseases over the last decades is a result of its cost-effective results and its ability…
  • 2022 International Congress

    Paraneoplastic Cerebellar Ataxia Due To Ovarian Teratoma: A Case Report

    R. Zouari, C. Jeridi, F. Nabli, MZ. Saeid, S. Blel, S. Ben Sassi (tunis, Tunisia)

    Objective: report the case of a young woman who presented with rapidly progressive ataxia caused by an ovarian teratoma Background: paraneoplastic cerebellar degeneration (PCD) is…
  • 2022 International Congress

    Influence of dopaminergig medication and subthalamic nucleus deep brain stimulation on impulsive decision making in Parkinson’s disease

    JC. Baldermann, A. Nehs, H. Jergas, H. Dafsari, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)

    Objective: To investigate how impulsive decision making is modulated by regular dopaminergic medication and by switching between active contacts of subthalamic nucleus stimulation Background: Impulsive…
  • 2022 International Congress

    Color vision deficits in Parkinson’s disease are linked to brain abnormalities in attentional, fronto-pariental and visual networks

    M. Diez-Cirarda, A. Murueta-Goyena, A. Miscioscia, R. Del Pino, S. Teijeira, MA. Acera, O. Lucas-Jimenez, N. Ojeda, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: To analyze the relationship between color vision deficits in Parkinson’s disease (PD) and the integrity of the visual system, cognition and other relevant networks…
  • 2022 International Congress

    Characteristics and Techniques to Improve Micrographia in Parkinson’s Disease

    S. Shahid (Southampton, USA)

    Objective: To analyze and identify the characteristics found in micrographia and provide methods of improving the symptom. Background: Micrographia, also known as small handwriting, is…
  • 2022 International Congress

    More than medications: Patient and care partner perspectives on care for Parkinson’s during hospitalization

    J. Shurer, N. Browner (New York, USA)

    Objective: To document and assess the needs, experiences, and self-reported challenges among patients and care partners that impact optimal care for Parkinson's disease (PD) during hospitalization.…
  • 2022 International Congress

    Assessment of microstructural changes associated with levodopa-induced dyskinesia in hemiparkinsonian rodents

    M. Bergamino, A. Fuentes, D. Marmion, I. Sandoval, C. Bishop, F. Manfredsson, A. Stokes (Phoenix, USA)

    Objective: To assess white matter (WM) microstructural integrity changes in pre-clinical models of Parkinson’s disease (PD) with levodopa-induced dyskinesia (LID). Background: PD is a neurodegenerative…
  • 2022 International Congress

    Challenges in diagnosis of hereditary ataxia and spastic paraplegias

    A. Planas-Ballvé, N. Caballol, X. Cardona, I. Gómez Ruiz, M. Balagué Marmaña, A. ávila (Barcelona, Spain)

    Objective: We aimed to investigate patients with hereditary ataxias (HA) and spastic paraplegias (HSP) followed in our hospital and to evaluate the percentage of patients…
  • 2022 International Congress

    Diagnosis of Niemann-Pick type C disease: adult onset form

    AM. Diezma-Martin, MI. Morales-Casado, P. Lobato Casado, JC. Segundo Rodriguez, F. Muñoz Escudero, DD. Garcia Melendez, N. Lopez Ariztegui (Toledo, Spain)

    Objective: We present a case of Niemann-Pick disease type C (NP-C) with adult onset. We review the clinical presentation, diagnosis and treatment of this rare…
  • 2022 International Congress

    DIFFERENCES IN KINEMATIC AND SPATIO-TEMPORAL PARAMETERS ASSESSED BY INSTRUMENTED “TIMED UP AND GO” TEST BETWEEN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS ASSOCIATED WITH PARKINSONISM AND PARKINSON’S DISEASE.

    G. Mostile, F. Contrafatto, R. Terranova, C. Terravecchia, A. Luca, M. Sinitò, G. Donzuso, CE. Cicero, G. Sciacca, A. Nicoletti, M. Zappia (Catania, Italy)

    Objective: To assess differences in quantitative gait parameters and motility during standardized tasks between idiopathic Normal Pressure Hydrocephalus associated with Parkinsonism (iNPH-P) and Parkinson’s Disease…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley